NCAM1 and rheumatoid arthritis: As shown in Figure 2a, the increase of CD14bright/CD56+ monocyte frequencies in the RA patients was limited to the age subset from 20–39 years, while frequencies in older RA patients did not differ significantly from age-matched controls.